AHSG and metabolic syndrome: Interestingly, both low and high levels of fetuin-A are linked to health risks: low levels are associated with increased cardiovascular mortality in dialysis patients, while elevated levels are linked to greater susceptibility to cardiovascular diseases, type 2 diabetes, and metabolic syndrome [12,13].